approval hub
A nonprofit group is suing the Trump administration over the process of updating the nation's dietary guidelines, alleging that the government improperly rewrote the guidelines with the help of a 'secret panel' of scientists backed by the beef and dairy industries.
The Internal Revenue Service is investigating UnitedHealth Group for allegedly funneling money through a foreign subsidiary to underpay taxes.
The use of wearable devices to track health metrics is being promoted by health insurance companies and the Department of Health and Human Services, but experts are raising concerns about the potential for increased costs and exploitation of personal data.
Luigi Mangione has pleaded guilty to federal stalking charges in the killing of UnitedHealthcare CEO Brian Thompson. Mangione admitted to trailing Thompson to an investor conference and shooting him on a New York City street in 2024.
The U.S. FDA has approved Bristol Myers Squibb’s oral drug iberdomide, marketed as Zenbexus, for use with daratumumab and dexamethasone in patients with relapsed or refractory multiple myeloma, marking the first approval of a novel drug class for the disease and the inaugural use of a more sensitive remission endpoint in the United States.
The U.S. FDA has approved Zenbexus, Bristol Myers Squibb’s oral treatment for advanced multiple myeloma, introducing a new class of blood cancer drugs known as CELMoDs. Meanwhile, a U.S. appeals court revived a $6.7 billion lawsuit accusing Bristol Myers of delaying regulatory approvals for three drugs post-Celgene acquisition.